Opens in a new tab

Financial calendar

Events option

2026 Extraordinary Shareholders Meeting (First Call)

First call to resolve on the following items in agenda:

1. Granting the Board of Directors, pursuant to Article 2443 of the Italian Civil Code, a delegated power to increase the share capital, free of charge and/or against payment, in one or more tranches, in divisible or indivisible form, with or without warrants, also with the exclusion of pre-emption rights pursuant to Article 2441, paragraphs 4, 5, 6 and/or 8, of the Italian Civil Code, and also pursuant to Article 2349 of the Italian Civil Code, for a maximum nominal amount of Euro 15,000,000.00 (fifteen million), plus share premium, through the issue of a maximum of 10,000,000 shares. Related and resulting resolutions.

2. Proposal to amend Articles 13 (Articles 108 and 111), 15 (Disclosure obligations in relation to significant shareholdings), 16 (Call and location of the Shareholders’ Meeting), 20 (Participation in and representation at the Shareholders’ Meeting), 21 (Chairman and Secretary of the Shareholders’ Meeting. Shareholders’ resolutions and minutes), 23 (Board of Directors), 29 (Delegation of powers) and 33 (Board of Statutory Auditors) of the Company’s By-Laws in order to align them with Legislative Decree No. 47/2026, and to grant the Board of Directors a delegated power to amend Article 12 (Provisions on public tender offers) of the By-Laws. Related and resulting resolutions.

2026 Extraordinary Shareholders Meeting (Second Call)

First call to resolve on the following items in agenda:

1. Granting the Board of Directors, pursuant to Article 2443 of the Italian Civil Code, a delegated power to increase the share capital, free of charge and/or against payment, in one or more tranches, in divisible or indivisible form, with or without warrants, also with the exclusion of pre-emption rights pursuant to Article 2441, paragraphs 4, 5, 6 and/or 8, of the Italian Civil Code, and also pursuant to Article 2349 of the Italian Civil Code, for a maximum nominal amount of Euro 15,000,000.00 (fifteen million), plus share premium, through the issue of a maximum of 10,000,000 shares. Related and resulting resolutions.

2. Proposal to amend Articles 13 (Articles 108 and 111), 15 (Disclosure obligations in relation to significant shareholdings), 16 (Call and location of the Shareholders’ Meeting), 20 (Participation in and representation at the Shareholders’ Meeting), 21 (Chairman and Secretary of the Shareholders’ Meeting. Shareholders’ resolutions and minutes), 23 (Board of Directors), 29 (Delegation of powers) and 33 (Board of Statutory Auditors) of the Company’s By-Laws in order to align them with Legislative Decree No. 47/2026, and to grant the Board of Directors a delegated power to amend Article 12 (Provisions on public tender offers) of the By-Laws. Related and resulting resolutions.

Board of Directors

BoD meeting to approve the consolidated half-yearly financial report as of 30 June 2026, voluntarily subjected to limited audit by the external auditing firm.

Board of Directors

BoD Meeting to review certain consolidated economic and financial management data for the six months ended 30 June 2026 (unaudited consolidated data).

Datrix at “CF&B Midcap Events – Frankfurt 2026” event, hosted by Banca Akros in collaboration with CF&B in Frankfurt

Datrix at “KT&Partners | Annual Investors Summit Day” event

Datrix at “AI Evolution, l’Italia che guida il cambiamento” hosted by Banca Akros, Lugano (CH)

Shareholders’ Meeting

Meeting, on second call, for the approval of the statutory financial statements for the year ended 31 December 2025 and presentation of the consolidated financial statements as of 31 December 2025.

Shareholders’ Meeting

Meeting, on first call, for the approval of the statutory financial statements for the year ended 31 December 2025 and presentation of the consolidated financial statements as of 31 December 2025.


Board of Directors Meeting

BoD meeting to approve the Draft Financial Statements for the financial year ended 31 December 2025 and approval of the Consolidated Financial Statements as of 31 December 2025.


Board of Directors Meeting

Review certain consolidated economic and financial management data for the financial year ended 31 December 2025 (unaudited consolidated data)

Board of Directors Meetings

Presentation of consolidated financial statements as of September 30, 2025 (consolidated data not subject to audit)